A case of apolipoprotein C-II deficiency with coronary artery disease

M Kawano1, K Kodama, H Inadera

  • 1Integrated Medicine, Omiya Medical Center, Jichi Medical School, Saitama, Japan. mkkawano@jichi.ac.jp

Insights

This study details a rare case of heterozygous apolipoprotein C-II deficiency linked to coronary artery disease in a 56-year-old male. The findings suggest a potential role for lipoprotein abnormalities in the development of atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Lipidology

Background:

  • Apolipoprotein C-II (ApoC-II) deficiency is a rare genetic disorder characterized by severe hypertriglyceridemia and recurrent pancreatitis.
  • Coronary artery disease (CAD) is a significant cause of morbidity and mortality, often associated with traditional risk factors.

Observation:

  • A 56-year-old male with diagnosed apolipoprotein C-II deficiency presented with myocardial infarction and complete coronary artery occlusions.
  • Lipid profile revealed significantly elevated postprandial triglycerides and low high-density lipoprotein cholesterol, with markedly reduced plasma apolipoprotein C-II levels.
  • Genetic analysis did not identify mutations in the common exons of the apolipoprotein C-II gene.

Findings:

  • The patient exhibited a very rare heterozygous form of apolipoprotein C-II deficiency.
  • Coronary atherosclerosis was observed in the absence of pancreatitis, a common complication of ApoC-II deficiency.
  • Lipoprotein abnormalities secondary to potential unidentified mutations in the apolipoprotein C-II gene are implicated in the development of CAD.

Implications:

  • This case highlights the potential for apolipoprotein C-II deficiency, even in its heterozygous and potentially milder forms, to contribute to premature coronary artery disease.
  • Further research into the genetic basis and clinical manifestations of less common apolipoprotein C-II deficiency variants is warranted.
  • Understanding the link between specific lipoprotein abnormalities and atherosclerosis in rare genetic disorders can inform risk stratification and management strategies for cardiovascular disease.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...